MX357018B - Method for the early diagnosis of hepatocellular carcinoma. - Google Patents
Method for the early diagnosis of hepatocellular carcinoma.Info
- Publication number
- MX357018B MX357018B MX2013015064A MX2013015064A MX357018B MX 357018 B MX357018 B MX 357018B MX 2013015064 A MX2013015064 A MX 2013015064A MX 2013015064 A MX2013015064 A MX 2013015064A MX 357018 B MX357018 B MX 357018B
- Authority
- MX
- Mexico
- Prior art keywords
- hepatocellular carcinoma
- early diagnosis
- ptgr1
- chc
- novel methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90206—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention relates to novel methods for the early diagnosis of hepatocellular carcinoma (CHC) by means of the detection of the genic products (mRNA or protein) of prostaglandin reductase 1 (Ptgr1) in biological samples, and to novel methods for determining whether a patient with CHC is a candidate for treatment with antitumoral compounds bioactivated by the Ptgr1.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2013015064A MX357018B (en) | 2013-12-18 | 2013-12-18 | Method for the early diagnosis of hepatocellular carcinoma. |
PCT/MX2014/000207 WO2015093932A1 (en) | 2013-12-18 | 2014-12-16 | Method for the early diagnosis of hepatocellular carcinoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2013015064A MX357018B (en) | 2013-12-18 | 2013-12-18 | Method for the early diagnosis of hepatocellular carcinoma. |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013015064A MX2013015064A (en) | 2015-06-18 |
MX357018B true MX357018B (en) | 2018-06-05 |
Family
ID=53403172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013015064A MX357018B (en) | 2013-12-18 | 2013-12-18 | Method for the early diagnosis of hepatocellular carcinoma. |
Country Status (2)
Country | Link |
---|---|
MX (1) | MX357018B (en) |
WO (1) | WO2015093932A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107663539B (en) * | 2017-09-29 | 2020-12-01 | 中山大学附属第三医院 | Use of circular RNA circ-PTGR1 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6974667B2 (en) * | 2000-06-14 | 2005-12-13 | Gene Logic, Inc. | Gene expression profiles in liver cancer |
DE10136273A1 (en) * | 2001-07-25 | 2003-02-13 | Sabine Debuschewitz | Molecular markers in hepatocellular carcinoma |
ATE493651T1 (en) * | 2002-07-03 | 2011-01-15 | Illumigen Biosciences Inc | METHODS AND COMPOSITIONS FOR DIAGNOSING HEPA CELL CARCINOMA |
EP1631682A1 (en) * | 2003-06-04 | 2006-03-08 | Agency for Science, Technology and Research | Differentially regulated hepatocellular carcinoma genes and uses thereof |
ES2324128A1 (en) * | 2005-09-29 | 2009-07-30 | Proyecto De Biomedicina Cima, S.L. | Molecular markers of hepatocellular carcinoma and their applications |
ATE542897T1 (en) * | 2006-06-09 | 2012-02-15 | Yakult Honsha Kk | GENE INVOLVED IN THE IMMORTALIZATION OF A HUMAN CANCER CELL AND USE THEREOF |
WO2013190075A2 (en) * | 2012-06-20 | 2013-12-27 | Meyer Helmut E | Specific biomarkers for hepatocellular carcinoma (hcc) |
-
2013
- 2013-12-18 MX MX2013015064A patent/MX357018B/en active IP Right Grant
-
2014
- 2014-12-16 WO PCT/MX2014/000207 patent/WO2015093932A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015093932A1 (en) | 2015-06-25 |
MX2013015064A (en) | 2015-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018008421A (en) | Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies. | |
CY1120390T1 (en) | COMPOSITION AND METHOD FOR DIAGNOSIS AND TREATMENT OF DISEASES RELATING TO NURSES | |
EA201792497A1 (en) | ANTIBODIES TO GITR FOR DIAGNOSIS OF MALIGNANT TUMOR | |
MX368513B (en) | Method for the diagnosis, prognosis and treatment of lung cancer metastasis. | |
MX2020001156A (en) | Method for the prognosis and treatment of cancer metastasis. | |
TN2013000358A1 (en) | Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects | |
BR112014029655A2 (en) | tissue preparation device, and method for preparing tissue | |
NZ584787A (en) | Inhibition of angiogenesis with a Bv8 antagonist | |
MX2021007667A (en) | Compositions and methods for detecting a biological contaminant. | |
EA201400117A1 (en) | METHODS AND NUCLEIC ACIDS FOR DETERMINATION OF THE PREDICTION IN CANCER PATIENTS | |
MX2020001193A (en) | Methods for determining dpp3 and therapeutic methods. | |
TW201613637A (en) | Methods of treating Alzheimer's Disease | |
WO2014057357A3 (en) | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis using c-maf | |
EA201690213A1 (en) | COMPOSITIONS AND METHOD FOR TREATMENT OF CONNECTED STATES | |
EA201790769A1 (en) | DETERMINATION OF THE LEVELS OF GLYCOSAMINOGLICANES BY THE MASS SPECTROMETRY METHOD | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
GB2523211A (en) | MCT protein inhibitor-related prognostic and therapeutic methods | |
MX2015015023A (en) | Method for determining free copper. | |
MX357018B (en) | Method for the early diagnosis of hepatocellular carcinoma. | |
GB2569932A (en) | Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment | |
MX2018000189A (en) | Method for the diagnosis of farber's disease. | |
UA86387U (en) | Method for evaluation of effectiveness of treatment of patients with arterial hypertension combined with metabolic syndrome | |
WO2016107874A3 (en) | Prenylcysteine oxidase 1 inhibitors for the prevention and/or treatment of oxidative stress-related degenerative diseases and prenylcysteine oxidase 1 as diagnostic marker | |
WO2013040071A3 (en) | Sperm protein as a detection biomarker of early stage ovarian cancer | |
UA82147U (en) | Method for prediction of emergence risk of ischaemic stroke |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |